Search Result "GSK-3β"
Amyloid Beta 1-42 Inhibits Entorhinal Cortex Activity in the Beta-Gamma Range: Role of GSK-3
Journal: Current Alzheimer Research
Volume: 9 Issue: 7 Year: 2012 Page: 857-863
Author(s): Fernando Pena-Ortega,Angeles Solis-Cisneros,Benito Ordaz,Hugo Balleza-Tapia,Juan Javier Lopez-Guerrero
Synthesis and Biological Evaluation of Novel 4-indolyl-5-phenyl(indolyl)- 1,2-dihydropyrazol-3-ones as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 9 Issue: 8 Year: 2012 Page: 780-788
Author(s): Hong Yin,Fengying Sui,Xinji Yang,Yingying Shangguan,Guojie Song
Lithium Pharmacodynamics and Pharmacogenetics: Focus on Inositol Mono Phosphatase (IMPase), Inositol Poliphosphatase (IPPase) and Glycogen Sinthase Kinase 3 Beta (GSK-3 Beta)
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2009 Page: 1917-1948
Author(s): Alessandro Serretti, Antonio Drago, Diana De Ronchi
The Role of Glycogen Synthase Kinase-3β in Normal Haematopoiesis, Angiogenesis and Leukaemia
Journal: Current Medicinal Chemistry
Volume: 15 Issue: 1 Year: 2008 Page: 1493-1499
Author(s): T. Holmes, T. A. OBrien, R. Knight, R. Lindeman, G. Symonds, A. Dolnikov
Roles of Glycogen Synthase Kinase 3 in Alzheimerâs Disease
Journal: Current Alzheimer Research
Volume: 9 Issue: 7 Year: 2012 Page: 864-879
Author(s): Zhiyou Cai,Yu Zhao,Bin Zhao
Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder
Journal: Current Drug Metabolism
Volume: 19 Issue: 8 Year: 2018 Page: 663-673
Author(s): Manoj P. Dandekar,Samira S. Valvassori,Gustavo C. Dal-Pont,Joao Quevedo
Recent Advances in the Discovery of GSK-3 Inhibitors from Synthetic Origin in the Treatment of Neurological Disorders
Journal: Current Drug Targets
Volume: 22 Issue: 12 Year: 2021 Page: 1437-1462
Author(s): Supriyo Saha,Dilipkumar Pal,Satish B. Nimse
GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 22 Year: 2022 Page: 2881-2895
Author(s):
Structural Analysis of Relevant Drug Targets for Alzheimer's Disease: Novel Approaches to Drug Development
Journal: Current Bioactive Compounds
Volume: 13 Issue: 2 Year: 2017 Page: 90-100
Author(s): Harolin M. Sosa,Renee Keyes,Kimberly A. Stieglitz
Targeting Signal Transduction Pathways in the Treatment of Mood Disorders: Recent Insights into the Relevance of the Wnt Pathway
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6 Issue: 3 Year: 2007 Page: 193-204
Author(s): Todd D. Gould, Eliot R. Dow, Kelley C. ODonnell, Guang Chen, Husseini K. Manji